Cargando…

Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment

Spinal cord injury (SCI) triggers a heterogeneous macrophage response that when experimentally polarized toward alternative forms of activation (M2 macrophages) promotes tissue and functional recovery. There are limited pharmacological therapies that can drive this reparative inflammatory state. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gensel, John C., Kopper, Timothy J., Zhang, Bei, Orr, Michael B., Bailey, William M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216345/ https://www.ncbi.nlm.nih.gov/pubmed/28057928 http://dx.doi.org/10.1038/srep40144

Ejemplares similares

Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury
por: Zhang, Bei, et al.
Publicado: (2015)

Delayed Azithromycin Treatment Improves Recovery After Mouse Spinal Cord Injury
por: Kopper, Timothy J., et al.
Publicado: (2019)

Continued development of azithromycin as a neuroprotective therapeutic for the treatment of spinal cord injury and other neurological conditions
por: Kopper, Timothy J., et al.
Publicado: (2020)

The effects of myelin on macrophage activation are phenotypic specific via cPLA(2) in the context of spinal cord injury inflammation
por: Kopper, Timothy J., et al.
Publicado: (2021)

Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
por: Venditto, Vincent J., et al.
Publicado: (2021)

Sexual Dimorphism of Pain Control: Analgesic Effects of Pioglitazone and Azithromycin in Chronic Spinal Cord Injury
por: Gensel, John C., et al.
Publicado: (2019)

Interactions of primary insult biomechanics and secondary cascades in spinal cord injury: implications for therapy
por: Orr, Michael B., et al.
Publicado: (2017)

Macrolide derivatives reduce proinflammatory macrophage activation and macrophage‐mediated neurotoxicity
por: Zhang, Bei, et al.
Publicado: (2019)

Therapeutic implications of advanced age at time of spinal cord injury
por: Stewart, Andrew N., et al.
Publicado: (2019)

Immunomodulatory Strategies for Spinal Cord Injury
por: Park, Jonghyuck
Publicado: (2022)

Acute inflammatory profiles differ with sex and age after spinal cord injury
por: Stewart, Andrew N., et al.
Publicado: (2021)

The effect of Lycium barbarum on spinal cord injury, particularly its relationship with M1 and M2 macrophage in rats
por: Zhang, Yu-Kai, et al.
Publicado: (2013)

Mitochondria exert age-divergent effects on recovery from spinal cord injury
por: Stewart, Andrew N., et al.
Publicado: (2021)

S100-β aggravates spinal cord injury via activation of M1 macrophage phenotype
por: Duan, Keke, et al.
Publicado: (2021)

Considerations for Studying Sex as a Biological Variable in Spinal Cord Injury
por: Stewart, Andrew N., et al.
Publicado: (2020)

Immunoglobulin G Is Increased in the Injured Spinal Cord in a Sex- and Age-Dependent Manner
por: Stewart, Andrew N., et al.
Publicado: (2022)

Immunomodulatory role of azithromycin: Potential applications to radiation-induced lung injury
por: Yan, Yujie, et al.
Publicado: (2023)

Corrigendum: Considerations for Studying Sex as a Biological Variable in Spinal Cord Injury
por: Stewart, Andrew N., et al.
Publicado: (2020)

Improving translatability of spinal cord injury research by including age as a demographic variable
por: Stewart, Andrew N., et al.
Publicado: (2022)

Neuroprotective effect of immunomodulatory peptides in rats with traumatic spinal cord injury
por: Parra-Villamar, Dulce, et al.
Publicado: (2020)

In Vitro Immunomodulatory Effects of Inonotus obliquus Extracts on Resting M0 Macrophages and LPS-Induced M1 Macrophages
por: Shen, Dayue, et al.
Publicado: (2022)

Data and subject heterogeneity and data sharing: keys to translational success in spinal cord injury research?
por: Fouad, Karim, et al.
Publicado: (2022)

Topiramate Treatment Is Neuroprotective and Reduces Oligodendrocyte Loss after Cervical Spinal Cord Injury
por: Gensel, John C., et al.
Publicado: (2012)

Advanced Age and Neurotrauma Diminish Glutathione and Impair Antioxidant Defense after Spinal Cord Injury
por: Stewart, Andrew N., et al.
Publicado: (2022)

Spatial and Cellular Characterization of mTORC1 Activation after Spinal Cord Injury Reveals Biphasic Increase Mainly Attributed to Microglia/Macrophages
por: Kjell, Jacob, et al.
Publicado: (2014)

Comprehensive landscape of immune-based classifier related to early diagnosis and macrophage M1 in spinal cord injury
por: Zhang, Zhao, et al.
Publicado: (2023)

UTX deletion promotes M2 macrophage polarization by epigenetically regulating endothelial cell-macrophage crosstalk after spinal cord injury
por: Peng, Wei, et al.
Publicado: (2023)

Effect of Sex on Motor Function, Lesion Size, and Neuropathic Pain after Contusion Spinal Cord Injury in Mice
por: McFarlane, Katelyn, et al.
Publicado: (2020)

PTEN knockout using retrogradely transported AAVs restores locomotor abilities in both acute and chronic spinal cord injury
por: Stewart, Andrew N., et al.
Publicado: (2023)

Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection
por: Khezri, Mohammad Rafi, et al.
Publicado: (2021)

Programmed Death 1 Deficiency Induces the Polarization of Macrophages/Microglia to the M1 Phenotype After Spinal Cord Injury in Mice
por: Yao, Anhui, et al.
Publicado: (2014)

Quercetin prevents necroptosis of oligodendrocytes by inhibiting macrophages/microglia polarization to M1 phenotype after spinal cord injury in rats
por: Fan, Hong, et al.
Publicado: (2019)

Anti-inflammatory and immunomodulatory effects of the extracellular vesicles derived from human umbilical cord mesenchymal stem cells on osteoarthritis via M2 macrophages
por: Li, Kanglu, et al.
Publicado: (2022)

Delayed inflammatory mRNA and protein expression after spinal cord injury
por: Byrnes, Kimberly R, et al.
Publicado: (2011)

Adoptive Transfer of Immunomodulatory M2 Macrophages Prevents Type 1 Diabetes in NOD Mice
por: Parsa, Roham, et al.
Publicado: (2012)

Engineered extracellular vesicles derived from primary M2 macrophages with anti-inflammatory and neuroprotective properties for the treatment of spinal cord injury
por: Zhang, Chuanjie, et al.
Publicado: (2021)

Mesenchymal Stem Cell-Derived Exosomal MiRNAs Promote M2 Macrophages Polarization: Therapeutic Opportunities for Spinal Cord Injury
por: Liang, Ze-Yan, et al.
Publicado: (2022)

Application of silver nanoparticles for improving motor recovery after spinal cord injury via reduction of pro-inflammatory M1 macrophages
por: Lin, Jie, et al.
Publicado: (2023)

Inhibition of Bruton Tyrosine Kinase Reduces Neuroimmune Cascade and Promotes Recovery after Spinal Cord Injury
por: Yu, Chen Guang, et al.
Publicado: (2021)

Intravenously delivered mesenchymal stem cell-derived exosomes target M2-type macrophages in the injured spinal cord
por: Lankford, Karen L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7iocmdbrrd8aiocuqrtdhdgb91